Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Stephen Landy

Neurology Tupelo, MS Medical Doctor

NPI 1528029618 CMS profile 205064

311 S Gloster St Ste 103, Tupelo, MS 38801

Open in the dashboard

General payments

$1,867,196

1,952 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stephen Landy of Tupelo, MS is reported in the CMS Open Payments database as having received $1,867,196 across 1,952 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $95,329 83
2024 General $156,721 162
2023 General $158,470 175
2022 General $332,818 308
2021 General $440,231 387
2020 General $339,097 344
2019 General $344,530 493

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Landy
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Stephen Landy were reported at $95,329. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Stephen Landy Neurology median Middle half National median
2019 $344,530 $474 $118–$2,177 $163
2020 $339,097 $367 $82–$2,309 $114
2021 $440,231 $438 $104–$2,547 $132
2022 $332,818 $442 $103–$2,388 $149
2023 $158,470 $464 $119–$2,312 $160
2024 $156,721 $468 $119–$2,323 $164
2025 $95,329 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $385,161 350 payments
  2. Allergan Inc. $348,525 343 payments
  3. Lilly USA, LLC $275,880 398 payments
  4. Amgen Inc. $244,958 268 payments
  5. Lundbeck LLC $222,828 253 payments
  6. Biohaven Pharmaceuticals, Inc. $109,256 91 payments
  7. Teva Pharmaceuticals USA, Inc. $94,414 85 payments
  8. Impel Pharmaceuticals Inc. $91,858 67 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $70,440 64 payments
  10. Biodelivery Sciences International, Inc. $10,661 15 payments
  11. Other $13,214 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,331,141 623 payments
  2. Consulting Fee $212,182 103 payments
  3. Honoraria $188,778 64 payments
  4. Travel and Lodging $103,782 549 payments
  5. Food and Beverage $27,872 606 payments
  6. Grant $3,210 3 payments
  7. Education $231 4 payments
Products named General payments · program years 2019–2025
  1. UBRELVY Neuroscience $229,703 195 payments
  2. AIMOVIG $216,558 244 payments
  3. BOTOX Neuroscience $216,035 180 payments
  4. NURTEC ODT $179,696 155 payments
  5. EMGALITY $161,085 202 payments
  6. VYEPTI $159,758 193 payments
  7. QULIPTA $127,254 109 payments
  8. UBRELVY Neuroscience $113,995 125 payments
  9. BOTOX Neuroscience $100,562 106 payments
  10. REYVOW $75,469 87 payments
  11. Other $283,758 280 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

1,952 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Mississippi

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record